TOHRU SATOH
President & CEO, Founder,
SONIRE Therapeutics Inc.
I was previously involved in the overseas development of Opdivo at Ono Pharmaceutical and established and managed overseas subsidiaries as a representative. I also served as Director of Business Planning at Oncolys Biopharma, and I was a board member of Liquid Biotech USA, which was launched from the University of Pennsylvania.
Sessions
-
16-Oct-2024